researchdrivelogo.jpg
Global Home Infusion Therapy Market Projected to Garner $49.5 Billion by 2027 and Witness Prominent Growth during the COVID-19 Pandemic – Exclusive Report [165 Pages] by Research Dive
September 20, 2021 09:00 ET | Research Dive
New York, USA, Sept. 20, 2021 (GLOBE NEWSWIRE) -- A research report published by Research dive on the global home infusion therapy market explains the impact of COVID-19 pandemic on the current...
researchdrivelogo.jpg
Global Home Infusion Therapy Market Predicted to Grow at a Revenue of $49.5 Billion at a CAGR of 11.7% during the Forecast Period, 2020-2027 – Exclusive Report [165 Pages] by Research Dive
June 03, 2021 09:00 ET | Research Dive
New York, USA, June 03, 2021 (GLOBE NEWSWIRE) -- According to a recent report by Research Dive, the global home infusion therapy market is anticipated to reach $49.5 billion by the end of 2026 at a...
ContraFect_LOGO_Web.jpg
ContraFect Announces Dr. Roger J. Pomerantz, Chief Executive Officer and Chairman, Invited as Keynote Speaker and Presenter in Maxim’s Infectious Disease Virtual Conference
April 21, 2020 07:00 ET | ContraFect Corporation
YONKERS, N.Y. , April 21, 2020 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of direct lytic agents...
Elite Pharmaceuticals, Inc. Logo
Elite Pharmaceuticals and SunGen Pharma File ANDA for an Antibiotic
January 03, 2019 07:30 ET | Elite Pharmaceuticals, Inc.
NORTHVALE, N.J., Jan. 03, 2019 (GLOBE NEWSWIRE) -- Elite Pharmaceuticals, Inc. ("Elite" or the “Company") (OTCBB: ELTP) a specialty pharmaceutical company developing abuse-deterrent opioids and...
ContraFect_LOGO_Web.jpg
ContraFect to Present at 2nd International Symposium on Antimicrobial Hydrolytic Enzymes
November 01, 2018 07:00 ET | ContraFect Corporation
YONKERS, N.Y., Nov. 01, 2018 (GLOBE NEWSWIRE) --  ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect_LOGO_Web.jpg
ContraFect to Present at the “Exploring the Antibiotic Pipeline 2018” Symposium and also to Present New Data on CF-301 (exebacase) at IDWeek 2018
September 25, 2018 07:00 ET | ContraFect Corporation
YONKERS, N.Y., Sept. 25, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
ContraFect_LOGO_Web.jpg
ContraFect to Participate in FDA Workshop on Development of Non-Traditional Therapies for Bacterial Infections
August 14, 2018 17:00 ET | ContraFect Corporation
YONKERS, N.Y., Aug. 14, 2018 (GLOBE NEWSWIRE) -- ContraFect Corporation (Nasdaq:CFRX), a clinical-stage biotechnology company focused on the discovery and development of protein and antibody...
gmi 2018.png
U.S. Home Infusion Therapy Market worth over $13.5 billion by 2024: Global Market Insights, Inc.
June 11, 2018 07:00 ET | Global Market Insights, Inc
Sellbyville, Delaware, June 11, 2018 (GLOBE NEWSWIRE) -- U.S. Home Infusion Therapy Market is poised to surpass USD 13.5 billion by 2024; according to a new research report by Global Market...
download.png
Farm Animal Drugs Market Size to be US$ 23,150 Mn by 2027 at CAGR 6.3%, Says a Research Report By Future Market Insights
December 15, 2017 04:22 ET | Future Market Insights Global and Consulting Pvt. Ltd.
Valley Cottage, NY, Dec. 15, 2017 (GLOBE NEWSWIRE) -- The global farm animal drugs market is expected to reflect a CAGR of 6.3% over the period starting from 2017 and forecasted till 2027 from the...
gmi logo.jpg
Home Infusion Therapy Market will grow at 9% to exceed 28bn by 2024: Global Market Insights, Inc.
November 14, 2017 05:00 ET | Global Market Insights, Inc
Ocean View, Delaware, Nov. 14, 2017 (GLOBE NEWSWIRE) -- Home Infusion Therapy Market is anticipated to cross USD 28 billion by 2024; according to a new research report by Global Market Insights....